ArticleFrontiers in pharmacology2022

Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone.

Carlos K H Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.